Abstract
The last decades have seen major developments in our knowledge of the different forms of neurofibromatosis (Ferner 2007a, b; Ferner et al. 2007; Friedman et al. 1999; Huson and Hughes 1994; Korf and Rubenstein 2005; North 1997; Ruggieri 2007; Upadhyaya and Cooper 1998a). Evidence based clinical diagnostic criteria and management guidelines have been developed (Baser et al. 2002; Ferner et al. 2007; Gutman et al. 1997; Listernick et al. 1997; Listernick and Charrow 2004a, b; North et al. 1997; Maria 2002; Ruggieri 1999; Wolkenstein et al. 1996). The genes for the two major forms, neurofibromatosis type 1 (NF1) and type 2 (NF2), have been cloned and the gene products, neurofibromin and merlin (also called Schwannomin), respectively, fully characterised (reviewed in Baser et al. 2003, Ferner 2007a, Friedman et al. 1999, Korf and Rubenstein 2005, Upadhyaya and Cooper 1998b).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abeliovich D, Gelman-Kohan Z, Silverstein S, Lerer I, Chemke J, Merlin S, Zlotogora J (1995) Familial cafe au lait spots: a variant of neurofibromatosis type 1. J Med Genet 32:985–986.
Abuelo DN, Meryash DL (1988) Neurofibromatosis with fully expressed Noonan syndrome. Am J Med Genet 29: 937–941.
Ahmadian MR, Hoffmann U, Goody RS, Wittinghofer A (1997) Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry 36: 4535–4541.
Ainsworth PJ, Chakraborty PK, Weksberg R (1997) Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion. Hum Mut 9: 452–457.
Akbarnia BA, Gabriel KR, Beckman E, Chalk D (1992) Prevalence of scoliosis in neurofibromatosis. Spine 17: S244–S248.
Akenside M (1768) Observations on cancers. Med Trans Coll Phys Lond 1: 64–92.
Albisi P, Balestri P, Bartalini G, Barardi A, Bergamaschi G, Bianchi E et al. (1993) Resultati dello studio collaborativo sulla neurofibromatosis tipe 1 (NF1) in Intalia. Riv Ital Pediatr 19:138–151.
Aldrovandi U (1642) Monstruorum Historia: Cum Paralipomenis Historiae omnium Animalium. Bologna: Typis Nocolai Tibaldini.
Allan BT (1985) Plexiform neurofibroma in neurofibromatosis. Am J Radiol 144:1300–1302.
Allanson JE, Hall JG, Van Allen MI (1985) Noonan phenotype associated with neurofibromatosis. Am J Med Genet 21: 457–462.
Allanson JE, Upadhyaya M, Watson GH, Partington M, MacKenzie A, Lahey D, MacLeod H, Sarfarazi M, Broadhead W, Harper PS, Huson SM (1991) Watson syndrome: is it a subtype of type 1 neurofibromatosis? J Med Genet 28: 752–756.
Alwan S, Tredwell SJ, Friedman JM (2005) Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 67: 378–390.
Anagnostouli M, Piperingos G, Yapijakis G, Gourtzetidis P, Balafouta S, Zournas C Vassilopoulos D, Koutras D, Papageorgiou C (2002) Thyroid gland neurofibroma in a NF 1 patient. Acta Neurol Scand 106: 58–61.
Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS (1993) A conserved alternative splice in the von Reck-linghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 13: 487–495.
Ars E, Kruyer H, Gaona A, Casquero P, Rosell J, Volpini V, Serra E, Lazaro C, Estivill X (1998) A clinical variant of neurofibromatosis type 1: familial spinal neurofibro-matosis with a frameshift mutation in the NF1 gene. Am J Hum Genet 62: 834–841.
Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X (2000a) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9: 28:1307–1312.
Ars E, Serra E, De la Luna S et al. (2000b) Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. NAR 28:1307–1312.
Artaza T, Garcia JF, Gonzalez C, Amengual M, Mazarro A, Rodriguez R (1999) Simultaneous involvement of the jejunum and the colon by type 1 neurofibromatosis. Scan J Gastroenterol 34: 331–334.
Arun D, Gutmann DH (2004) Recent advances in neurofibromatosis type 1. Curr Opin Neurol 17:101–105.
Atit RP, Crowe MJ, Greenheigh DG, Wenetrup RJ, Ratner N (1999) The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 112: 835–842.
Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo Tamula MA, O’Neill BP, Fox E, MacDonald T, Beck H, Packer RJ (2007) Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol 36: 293–300.
Bahuau M, Flintoff W, Assouline B, Lyonnet S, Le Merrer M, Prieur M, Guilloud-Bataille M, Feingold N, Munnich A, Vidaud M, Vidaud D (1996) Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association. Am J Med Genet 66: 347–355.
Bahuau M, Houdayer C, Assouline B, Blanchet-Bardon C, Le Merrer MI, Lyonnet SI, Giraud S, Recan D, Lakhdar H, Vidaud Ml, Vidaud D (1998) Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome. Am J Med Genet 75: 265–272.
Bahuau M, Pelet A, Vidaud D, Lamireau T, Bail B, Munnich A, Vidaud M, Lyonnet S, Lacombe D (2001) GDNF as a candidate modifier for neurofibromatosis enteric phenotype. J Med Gene 38: 638–643.
Bajenaru ML, Herandez MR, Perry A, Zhu Y, Parada LF, Garbow JR, Gutmann DH (2003) Optic nerve glioma in mice requires astrocyte Nfl gene inactivation and brain heterozygosity. Cancer Res 63: 8573–8577.
Balestri P, Vivarelli R, Grosso S, Santori L, Farnetani MA, Galluzzi P, Vatti GP, Calabrese F, Morgese G (2003) Malformations of cortical development in neurofibromatosis type 1. Neurology 61:1799–1801.
Baltrusaitis J (1960) Reveil et prodiges. Le gothique fantastique. Paris: Armand Colin, pp. 105–106, 349, nota 59.
Baralle D, Mattocks C, Kalidas K, Elmslie F, Whittaker J, Lees M, Ragge N, Patton MA, Winter RM, Affrench-Constant C (2003) Different mutations in the NF1 gene are associated with neurofibromatosis-Noonan syndrome (NFNS). Am J Med Genet 119A: 1–8.
Barber JC, Cross IE, Douglas F, Nicholson JC, Moore KJ, Browne CE (1998) Neurofibromatosis pseudogene amplification underlies euchromatic cytogenetic duplications and triplications of proximal 15q. Hum Gen 103: 600–607.
Barkovich AJ (2005) The Phakomatoses. In: Barkovich AJ (ed.) Pediatrie neuroimaging. Philadelphia: Lippincott Williams & Wilkins, pp. 245–289.
Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG (2002) Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59:1759–1765.
Bass JC, Korobkin M, Francis IR, Ellis JH, Cohan RH (1994) Retroperineal plexiform neurofibromas: CT findings. A J Radiol AJR 163: 617–620.
Basu TN, Gutmann DH, Fletcher JA, Glover TV, Collins FS, Downward J (1992) Aberrant regulation of ras proteins in malignant tumor cells from type 1 neurofibromatosis patients. Nature 356: 713–715.
Baujat B, Krastinova-Lolov D, Blumen M, Baglin AC, Coquille F, Chabolle F. (2006) Radiofrequency in the treatment of craniofacial plexiform neurofibromatosis: a pilot study. Plast Reconstr Surg 117:1261–1268.
Bergin DJ, Johnson TE, Spencer WH, McCord D (1988) Ganglioglioma of the optic nerve. Am J Ophthalmol 105:146–149.
Bernards A, Snijders AJ, Hannigan GE, Murthy AE, Gusella JF (1993) Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments. Hum Mol Genet 2: 645–650.
Berner JM, Sorile T, Mertons F, Henriksen J, Saeter G, Mandahl N, Brogger A, Myklebost O, Lothe RA (1999) Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 26:151–160.
Bertholon J, Wang Q, Galmarin C, Puisieux A (2006) Mutational targets in colorectal cancer cells with microsatellite instability. Fam Can 5: 29–34.
Bertola DR, Pereira AC, Passetti F, de Oliveira PS, Messiaen L, Gelb BD, Kim CA, Krieger JE (2005) Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. Am J Med Genet A136:242–245.
Birch R (1993) Peripheral nerve tumors. In: Dyck PJ, Thomas RK (eds.) Peripheral nerve tumors. Philadelphia: WB Saunders, pp. 1623–1640.
Blatt J, Jaffe R, Deutsch M, Adkins JC (1986) Neurofibromatosis in childhood tumours. Cancer 57: 1225–1229.
Bodhey NK, Gupta AK (2006) Neurofibromatosis type I with occipital encephalocele. Neurol India 54: 103–104.
Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC (1988) Cranial MR imaging in neurofibromatosis. Am J Roentgenol 151: 381–388.
Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K (1995) Loss of NF1 results in activation of the Ras signalling pathway and leads to aberrant growth in growth heamatopoletic cells. Nature 12:144–148.
Boltshauser E, Stocker H, Machler M (1989) Neurofibromatosis type 1 in a child of a parent with segmental neurofibromatosis (NF-5). Neurofibromatosis 2: 244–245
Boulanger JM, Larbrisseau A (2005) Neurofibromatosis type 1 in a pediatrie population: Ste-Justine’s experience. Can J Neurol Sci 32: 225–231.
Boyanapalli M, Lahoud OB, Messiaen L, Kim B, Anderle de Sylor MS, Duckett SJ, Somara S, Mikol DD (2006) Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. Biochem Biophys Res Commun 24(340): 1200–1208.
Broniscer A, Gajjar A, Bhargava R, Langston JW, Heideman R, Jones D (1997) Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the detection from diffuse pontine glioma. Neurosurgery 40: 331–338.
Brunner H, Stacher G, Bankl H, Grabner G (1974) Chronic mesenteric arterial insufficiency caused by vascular neurofibromatosis. Am J Gastroenterol 62: 442–447.
Brunner HG, Hulsebos T, Steijlen PM, der Kinderen DJ, van den Steen A, Hamel BCJ (1993) Exclusion of the neurofibromatosis 1 locus in a family with inherited cafe-au-lait spots. Am J Med Genet 46:472–474.
Brzowski AE, Bazan C, Mumma JV, Ryan SG (1992) Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 42: 679–681.
Burgdorf WH, Zeiger B (2004) JXG, NF1, and JMML: alphabet soup or a clinical issue? Pediatr Dermatol 21: 174–176.
Cakirer S, Karaarslan E (2004) Spontaneous involution of a non-optic astrocitoma in neurofibromatosis type 1: serial magnetic resonance imaging evaluation. Acta Radiol 45: 669–673.
Cambiaghi S, Restano L, Caputo R (2004) Juvenile xan-thogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologie malignancies. Pediatr Dermatol 21: 97–101.
Cappione AJ, French BL, Skuse GR (1997) A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am J Hum Genet 60: 305–312.
Caprotti E (1980) Mostri. Draghi e Serpenti nelle Xilografie di Ulisse Aldrovandi e dei suoi Contemporanei. Milano: Mazzotta.
Carella A, Medicamento N (1997) Malignant evolution of presumed benign lesions in the brain in neurofibromatosis: case report. Neuroradiology 39: 639–641.
Carey JC (1998) Neurofibromatosis-Noonan syndrome. Am J Med Genet 75:263–264.
Carey JC, Stevenson DA, Ota M, Neil S, Viskochil DH (1997) Is there an NF/Noonan syndrome: Part 2. Documentation of the clinical and molecular aspects of an important family. Proc Greenwood Genet Center 17: 152–153 (Abstract).
Carmi D, Shohat M, Meztker A, Dickerman Z (1999) Growth, puberty and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: A longitudinal study. Pediatrics 103:1257–1262.
Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R (1995) Proton M spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. Am J Neuroradiol 16:141–147.
Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M (2003) Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet 40: el09.
Ceard J (1971) Ambroise Parè. Des Monstres et prodiges. Edition critique e commentèe. Geneve: Libraire Droz: p. 101.
Chaglassian JH, Riseborough EJ, Hall JE (1976) Neurofibromatous scoliosis: natural history and results of treatment in thirty-seven cases. J Bone Joint Surg 58A: 695–702.
Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR (2007) Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Invest Ophthalmol Vis Sci 48: 2895–2902.
Chang BS, Apse KA, Caraballo R, Cross JH, Mclellan A, Jacobson D, Valente KD, Barkovich AJ, Walsh A (2006) A familial syndrome of unilateral polymicrogyria affecting the right hemisphere. Neurology 66: 133–135.
Chang-Lao M (1977) Laryngeal involvement in von Reck-linghausen’s disease: a case report and review of the literature. Laryncoscope 87: 435–442.
Chapman CA, Waber DP, Bassett N, Urion DK, Korf BR (1996) Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. Am J Med Genet Neuropsychiatric Genetics 67:127–132.
Charrow J, Listernick R, Ward K (1993) Autosomal dominant multiple cafe-au-lait spots and neurofibromatosis-1: evidence of non-linkage. Am J Med Genet 45:606–608.
Chen PC, Ball WS, Towbin RB (1989) Aggressive fibromatosis of the tongue: MR demonstration. J Comp Assist Tomogr 13: 343–345.
Choulant L (1963) Grapische Incunabeln fr Naturgeschichte und Medizin. Leipzig, 1858, reprinted Hildesheim: Georg Olms, p. 113.
Chow LT, Shum BS, Chow WH (1993) Intrathoracic vagus nerve neurofibroma and sudden death in a patient with neurofibromatosis. Thorax 48: 298–299.
Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T (1999) Mouse models of tumor development in neurofibromatosis type 1. Science 286: 2172–2176.
Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593–604.
Cichowski K, Santiago S, Jardim M, Johnson BW, Jacks T (2003) Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev 17: 449–454.
Clark M, Neville BG (2008) Familial and genetic associations in Worster-Drought syndrome and perisylvian disorders. Am J Med Genet A 146: 35–42.
Clausen N, Andersson P, Tommerup N (1989) Familial occurrence of neuroblastomas, von Recklinghausen’s neurofibromatosis, Hirschprum’s agangliosis and Jawwinking syndrome. Acta Pediatr Scan 78: 736–741.
Clementi M, Battistella PA, Rizzi L, Boni S, Tenconi R (1996) Headache in patients with neurofibromatosis type 1. Headache 36:10.
Cnossen MH, Stam EN, Cociman LCMG, Simonz HJ, Stroink H, Oranje AP, Halley DJ, de Goede-Bolder A, Niermeijer MF, de Muinck Keizer-Schrama SM (1997) Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics 100: 667–670.
Cnossen MH, de Goede-Bolder A, van den Broek KM, Waasdorp CME, Oranje AP, Stroink H, Simonsz HJ, van den Ouweland AM, Halley DJ, Niermeijer MF (1998a) A prospective 10 years follow-up study of patients with neurofibromatosis type 1. Arch Dis Child 78: 408–412.
Cnossen MH, Moon KGM, Garssen MPJ, Pasmans NM, de Goede-Bolder A, Niermeijer MF, Grobbee DE (1998b) Minor disease features in neurofibromatosis type 1 (Nf1) and their possible value in diagnosis of Nf1 children <6 years and clinically suspected of having Nf1. J Med Genet 35:624–627.
Colledge L (1930) Two tumors of the peripheral nerves. I. Neurofibromas of the pharynx in the course of von Recklinghausen’s disease. J Laryngol Otol 45: 409–410.
Colley A, Donnai D, Evans DGR (1996) Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 49: 59–64.
Colman SD, Williams CA, Wallace MR (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11: 90–92.
Consoli C, Moss C, Gren S, Balderson D, Cooper DN, Upadhyaya M (2004) Gonosomal mosaicism for a nonsense mutation (R1947X) in an individual with segmental neurofibromatosis typel (SNF1). J Invest Dermatol 125: 463–466.
Corkill AGL, Ross CF (1969) A case of neurofibromatosis complicated by medulloblastoma, neurogenic sarcoma and radiation-induced carcinoma of thyroid. J Neurol Neurosurg Psychiatr 32: 43–47.
Costa RM, Yang T, Huynh DP, Pulst SM, Viskochil DH, Silva AJ, Brannan CI (2001) Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet 27: 399–405.
Costa RM, Silva AJ (2002) Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1. J Child Neurol 17: 622–626.
Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ (2002) Mechanism for learning deficits in a mouse model of neurofibromatosis type 1. Nature 415: 526–530.
Crawford MJ, Buckler JMH (1983) Optic gliomata affecting twins with neurofibromatosis. Dev Med Child Neurol 25: 370–373.
Crawford AH, Bagamery N (1986) Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 6: 72–88.
Crawford AH, Schorry EK (2006) Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg 7: 217–230.
Crawford AH, Schorry EK (2006) Neurofibromatosis update. J Pediatr Orthop 26: 413–423.
Crèange A, Zeller J, Rostaing-Rigattieri S, Brugieres P, Degos JD, Revuz J, Wolkenstein P (1999) Neurological complications of neurofibromatosis type 1 in adulthood. Brain 122: 473–481.
Crowe FW, Schull WJ, Neel JV (1956) Clinical, pathological, and genetic study of multiple neurofibromatosis. Springfield, III, Charles C Thomas, pp. 1–181.
Cusmai R, CurDe Luca atolo P, Mangano S, Cheminai R, Echenne B (1990) Hemimegalencephaly and neurofibromatosis. Neuropediatrics 21:179–182.
Czyzyk E, Jozwiak S, Roszkowski M, Schwartz RA (2003) Optic pathway gliomas with and without neuofibromatosis 1. J Child Neurol 18: 471–478.
D’Ambrosio J, Langlais R, YRS (1988) Jaw and skull changes in neurofibromatosis. Oral Surg Oral Med Oral Pathol 66: 391–396.
D’Angelo I, Welti S, Bonneau F, Scheffzek K (2006) A novel bipartite phospholipids-binding module in neurofibromatosis type 1 protein. EMBO reports.
Danglot G, Régnier V, Fauvet D, Vassal G, Kujas M, Bernheim A (1995) Neurofibromatosis 1 (Nf1) mRNAs expressed in the central nervous system are differentially spliced in the 5’ part of the gene. Hum Mol Genet 4:915–920.
Dasgupta B, Gutmann DH (2003) Neurofibromatosis type 1: closing the GAP between mice and men. Curr Opin Genet Dev 13: 20–27.
Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH (2005) Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Can Res 5: 2775–2760.
Davies RL (2000) Neurofibromin progress on the fly. Nature 403: 846–847.
DeBella K, Szudek J, Friedman JM (2000) Use of the NIH criteria for diagnosis of NF1 in children. Pediatrics 105: 608–614.
DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR (1992) Abnormal regulation of mammalian p21 Ras contributes to malignant tumour growth in neurofibromatosis type 1. Cell 89: 266–273.
DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rul W, Vess WC, Viskochil D, Ratner N (2000) Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Clin Invest 105:1233–1241.
De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B (2005) NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet 77: 1092–1101.
Deniz E, Shimkus GJ, Weller CG (1966) Pelvic neurofibromatosis: localized von Recklinghausen’s disease of the bladder. J Urol 96: 906–909.
De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E (2003) Elevated risk for MPNST in NF1 microdele-tion patients. Am J Hum Genet 72:1288–1292.
De Raedt T, Brems H, Lopez-Correa C, Vermeesch JR, Marynen P, Legius E (2004) Genomic organization and evolution of the NF1 microdeletion region. Genomics 84: 346–360.
De Raedt T, Maertens O, Brems H, Heyns I, Sciot R, Majounie E, Upadhyaya M, Speleman F, Messiaen L, Joris R, Vermeesch JR, Legius E (2006) Loss of heterozygosity in neurofibromas: comparison of NF1 microdeletion and non-microdeletion patients. Genes Chromosome Cancer 45: 893–904.
De Smet L, Sciot R, Legius E (2002) Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1. J Med Genet 39: e45.
De Winter AE, Moore BD III, Slopis JM, Ater JL, Copeland DR (1999) Brain tumors in children with neurofibromatosis: additional neuropsychological morbidity? Neuro-Oncology: 1: 275–281.
Deux livres de chirurgie (1573) 1. De la generation de l’homme-2. Des monstres tant terrestres, que marins, aveuc leurs portraits …. Par Ambroise Paré, premier chirurgien du Roy, et iurè a Paris. A Paris, chez André Wechel,……
DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT (1995) Neurofibromatosis type 1: pathologic sub strate of high signal intensity foci in the brain. Radiology 195: 721–724.
Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K (2000) NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 9: 35–46.
Ducatman B, Scheithauer B, Piepgras D, Reiman H, Istrup D (1986) Malignant peripheral nerve sheath tumors: a clinicopathological study of 120 patients. Cancer 57: 2006–2021.
Dugoff L, Sujansky E (1996) Neurofibromatosis type 1 and pregnancy. Am J Med Genet 66: 7–10.
Dulai S, Briody J, Schindeler A, North KN, Cowell CT, Little DG (2007) Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthop 27: 472–475.
Duman O, Ozdem S, Turkkahraman D, Olgac ND, Gungor F, Haspolat S (2008) Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1. Brain Dev Mar 24 [Epub ahead of print].
Dunn DW (1987) Neurofibromatosis in childhood. Curr Probl Pediatr 17: 451–497.
Duve S, Rakoski J (1994) Cutaneous melanoma in patient with neurofibromatosis: a case report and review of the literature. Br J Dermatol 131:290–294.
Easton DF, Ponder MA, Huson SM, Ponder BA (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53: 305–313.
Egelhoff JC, Bates DJ, Ross JS, Rothner AD, Cohen BH (1992) Spinal MR findings in neurofibromatosis types 1 and 2. Am J Neuroradiol 13:1071–1073.
Eisenbarth I, Beyer K, Krone W, Assum G (2000) Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet 66: 393–401.
Eliason MJ (1986) Neurofibromatosis: implications for learning and behaviour. Dev Behav Pediatr 7: 175–179.
El-Koussy M, Lövbland K-O, Steinlin M, Kiefer C, Schroth G (2002) Perfusion MRI abnormalities in the absence of diffusiön changes in a case of moyamoya-like syndrome in neurofibromatosis type 1. Neuroradiology 44: 938–941.
Enzinger FM, Weis SW (1988) Soft tissue tumors, 2nd ed. St Louis: Mosby, pp. 719–780.
Erbay SA, Oljeski SA, Bhadelia R (2004) Rapid development of optic glioma in a patient with hybrid phakomatosis: neurofibromatosis type 1 and tuberous sclerosis. Am J Neuroradiol 25:1297–1298.
Evans DRG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002b) Malignant peripheral nerve sheath tu-mours in neurofibromatosis 1. J Med Genet 39: 311–314.
Evans DRG, Baser ME, Mc Gaughran J, Sharif S, Howard E, Moran A (2002b) Malignant peripheral fluorodeoxyglucosa positron emission tomography (FDG PET) in the detection of malignant peripheral nerve sheath tumors arising from within plexiform tumors in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68: 353–357.
Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kucukceylan N, Abdel-Nour M, Gewies A, Peters H, Kaufmann D, Buske A, Tinschert S, Nurnberg P (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 66: 790–818.
Fantes JA, Mewborn SK, Lese CM, Hedrick J, Brown RL, Dyomin V, Chaganti RS, Christian SL, Ledbetter DH (2002) Organisation of the pericentric region o chromosome 15: at least four partial gene copies are amplified in patients with a proximal duplication of 15q. J Med Genet 39:170–177.
Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RAC (1993) MRI in neurofibromatosis 1-the nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56: 492–495.
Ferner RE, Lucas JD, O’Doherty MJ, Hughes RA, Smith MA, Cronin BF, Bingham J (2000a) Evaluation of (18) fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68: 353–357.
Ferner RE, Lucas JD, O’Doherty MJ, Hughes RAC, Smith MA, Cromin BF (2000b) Evaluation of (18) nerve sheath tumors in neurofibromatosis. J Med Genet 39: 311–314.
Ferner RE, Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62:1573–1577.
Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR (2004) Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet 41: 837–841.
Ferner RE (2007a) Neurofibromatosis 1. Eur J Hum Genet 15:131–138.
Ferner RE (2007b) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 6: 340–351.
Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis l.J Med Genet 44: 81–88.
Finley JL, Dabbs BJ (1988) Renal vascular smooth muscle proliferation in neurofibromatosis. Hum Pathol 19: 107–110.
Finman NL, Yakovac WC (1970) Neurofibromatosis in childhood. J Pediatr 76: 339–346.
Fitzpatrick AP, Emanuel RW (1988) Familial neurofibromatosis hypertrophic cardiomyopathy. Br Heart 60: 247–261.
Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1728 patients. Am J Med Genet 70:138–143.
Friedman JM, Birch PH, and the NNFF International Database Participants (1997) Cardiovascular malformations in NF1 (abstract) Am J Hum Genet 61: A98.
Friedman JM, Gutmann DH, MacCollin M, Riccardi V (1999) Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press.
Friedrich RE, Giese M, Schmelzle R, Mautner VF, Scheuer HA (2003) Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings. J Craniomax-illofac Surg 31:1–9.
Fuller CE, Williams GT (1991) Gastrointestinal manifestations of type 1 neurofibromatosis (von Reckling-hausen’s disease. Histopathology 19:1–11.
Fuller LC, Cox B, Gardner RJ (1989) Prevalence of von Recklinghausen neurofibromatosis in Dunedin, New Zealand. Neurofibromatosis 2: 278–288.
Gabriele AL, Grifa D, Thomas NS, Ruggieri M, Carella M, Larizza L, Clementi M, Bonioli E, De Luca A, Pavone P, Polizzi A, Origone P, Riva P, Peluso G, Sprovieri T, Patitucci T, Magariello A, Muglia M, Mazzei R, Conforti FL, Augello B, Stanziale P, Muscarella L, Iannetti P, Pascali MP, Bavastrelli M, Dallapiccola B, Upadhyaya M, Quattrone A, Zelante L (2007) Molecular testing in neurofibromatosis type 1 (NF1): The mutational spectrum, patterns of recurrence and correlations with clinical features in a large cohort of Italian NF1 patients. Hum Mutat (in press).
Gadner H, Haas OA (1992) Experience in pediatric myelodysplastic syndromes. Hematol Oncol Clin North Am 6: 655–672.
Garty BZ, Laor A, Danon YL (1994) Neurofibromatosis type 1 in Israel: survey of young adults. J Med Genet 31: 853–857.
Garvey M, Packer RJ (1996) An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. 28: 167–183.
Gasparini P, Grifa A, Origone P, Coviello D, Antonacci R, Rocchi M (1993) Detection of a neurofibromatosis type 1 homologous sequence by PCR: implications for the diagnosis and screening of genetic disease. Mol Cell Probes 7: 415–418.
Gervanasini C, Bentivegna A, Venturin M, Corrado L, Larizza L, Riva P (2002) Tandem duplication of the NF1 gene detected by high-resolution FISH in the 17qll.2 region. Hum Genet 110(4): 314–321.
Gilberg C, Forseil C (1984) Childhood psychosis and neurofibromatosis more than a coincidence. J Autism Dev Disord 14:1–8.
Gitler AD, Zhu Y, Ismat FA, Lu M, Yamauchi Y, Parada L, Epstein JA (2003) NF1 has an essential role in endothelial cells. Nat Genet 33: 75–79.
Gorlin R, Cohen MM Jr, Levine M (2005) The neurofibromatoses [NFI Recklinghausen type, NFII acoustic type, other types]. In: Gorlin R, Cohen MM Jr, Levine M: Syndromes of the head and neck. Oxford: Oxford University Press, pp. 392–399.
Greager JA, Reichard KW, Campana JP, Das Gupta TK (1992) Malignant schwannoma of the head and neck. Am J Surg 163: 440–442.
Greene JF, Fitzwater JE, Burgess J (1974) Arterial lesions associated with neurofibromatosis. Am J Clin Pathol 62: 481–487.
Gregory PE, Gutmann DH, Mitchell A, Park S, Boguski M, Jacks T, Wood DL, Jove R, Collins FS (1993) Neurofibromatosis type 1 gene product (Neurofibromin) associates with microtubules. Somat Cell Molec Genet 19:265–274.
Griebel ML, Redman JF, Kemp SF, Elders MJ (1991) Hypertrophy of clitoral hood: presenting sign of neurofibromatosis in female child. Urology 37: 337–339.
Griffiths AP, White J, Dawson A (1998) Spontaneous hemithorax: a cause of sudden death in von Reckling-hausen’s disease. Postgra Med J 74: 679–681.
Grill F, Bollini C, Dungl P (2000) Treatment approaches for congenital pseudoarthrosis of tibia: results of the EPOS multicenter study. Eur Paediatr Othopaed Soc J Pediatr Orthop B 9: 75–89.
Guha A, Lau N, Huvar I, Gutmann D, Provian J, Pawson T, Boss G (1996) Ras-GTP levels are elevated in human NF1 peripheral nerve tumours. Oncogene 12: 507–513.
Guillamo JS, Créange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P; RÈseau NF France (2003) Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1). A retrospective study of 104 patients. Brain 126: 152–160.
Guo HF, The I, Hannan F, Bernards A, Zhong Y (1997) Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 276: 795–798.
Guo HF, Tong J, Hannan F, Luo L, Zhong Y (2000) A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 403: 895–898.
Gupta A, Cohen BH, Ruggieri P, Packer RJ, Phillips PC (2003) Phase I study of thalidomide for the treatment o gra nuloma in neurofibromatosis 1. Neurology 60:130–132.
Gurney JG, Shannon KM, Gutmann DH (1996) Juvenile xanthogranuloma neurofibromatosis 1 and juvenile chronic myeloid leukaemia. Arch Dermatol 132: 1390.
Gurujeyalakshmi G, Hollinger MA, Giri SN (1999) Perfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Psysiol 276: L311–L318.
Gutmann D, Andersen L, Cole J (1993) An alternatively spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum Mol Genet 2: 989–992.
Gutman DH, Aynsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278: 51–57.
Gutman DH (2002) Neurofibromin in the brain. J Child Neurol 17: 592–601.
Gutzmer R, Herbst RA, Mommert S, Kiehl P, Matiaske F, Riitten A, Kapp A, Weiss J (2000) Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in dermoplastic neurotropic melanoma. Hum Genet 107: 357–361.
Habiby R, Silverman B, Listernick R, Charrow J (1994) Precocious puberty in children with neurofibromatosis type 1. J Pediatr 125: 63–66.
Hagymasi L, Toth M, Szucs N, Rigo J Jr (1998) Neurofibromatosis type 1 with pregnancy associated renovascular hypertension and the syndrome of hemolysis, elevated liver enzymes, and low platelets. Am J Obst Gynecol 179:272–274.
Hajra A, Martin-Gallardo A, Tarie SA, Freedman M, Wilson-Gunn S, Bernards A, Collins FS (1994) DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. Genomics 21: 649–652.
Hakami MA, Speicher DW, Shiekhattar R (2002) The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis. J Boil Chem 277: 36909–36912.
Halliday AL, Sobel RA, Martuza RL (1991) Benign spinal nerve sheath tumours: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74:248–253.
Halper J, Factor SM (1984) Coronary lesions in neurofibromatosis associated with vasospasms and myocardial infarction. Am Heart J 108: 420–422.
Hamilton SJ, Allard MF, Friedman JM (2001) Cardiac findings in an individual with neurofibromatosis 1 and sudden death. Am J Med Genet 100: 95–99.
Happle R (1993) Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 129: 1460–1470.
Happle R (1997) A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 133:1505–1509.
Harber D, Harlow E (1997) Tumour-supressor genes: evolving definitions in the genomic age. Nature Gen 16: 320–332.
Hashemian H (1952) Familial fibromatosis of small intestine. Brit J Surg 40: 346–350.
Hecht F (1989) Recognition of neurofibromatosis before von Recklinghausen. Neurofibromatosis 2:180–184.
Heimann R, Verhest A, Verschraegen J, Grosjean W, Draps JP, Hecht F (1988) Hereditary intestinal neurofibromatosis. I. A distinctive genetic disease. Neurofibromatosis 1: 26–32.
Hess E (1938) Sarcoma of the prostate and adjacent retrovesical structures. J Urol 40: 629–640.
Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW (2001) Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/-cells. J Biol Chem 276(10): 7240–7245.
Hochberg FA, Dasilva AB, Galdabini J, Richardson EP (1974) Gastrointestinal involvement in von Recklinghausens neurofibromatosis. Neurology 24:1144–1151.
Hochstrasser H, Boltshauser E, Valavanis A (1988) Brain tumors in children with von Recklinghausen neurofibromatosis. Neurofibromatosis 1: 233–238.
Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker IE, Jenkin D, Greenbery M (1993) Optic pathway/ hypothalamic gliomas: a dilemma in management. Pediatr Neurosurg 19:186–195.
Hoffmeyer S, Nunberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D, Krone W (1998) Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet 62: 269–277.
Holt JF (1977) Neurofibromatosis in children. Edward BD Neuhaser lecture. Am J Radiol 130: 615–639.
Hoo JJ, Shrimpton AE (2005) Familial hyper-and hypopig-mentation with age-related pattern change. Am J Med Genet 132A: 215–218.
Hope DG, Mulvihill JJ (1981) Malignancy in neurofibromatosis. Adv Neurol 29: 33–36.
Horan M, Cooper DN, Upadhyaya M (2001) Site-specific methylation of the neurofibromatosis type 1 gene promoter bis rarely involved in NF1 gene inactivation in NF1-specific tumours. Hum Genet 107: 33–39.
Horan M, Osborm M, Cooper DN, Upadhyaya M (2004) Functional analysis of polymorphic variation within the promoter and 5’ untranslated region of the neurofibromatosis type 1 (NF1) gene. Am J Med Genet 131A: 227–231.
Horwich A, Riccardi VM, Francke U (1983) Aqueductal stenosis leading to hydrocephalus-an unusual manifestation of neurofibromatosis. Am J Med Genet 14: 577–581.
Hosoda K, Kanazawa Y, Tanaka J, Tamaki N, Matsumoto S (1986) Neurofibromatosis presenting with aqueductal stenosis due to a tumor of the aqueduct: case report. Neurosurgery 19:1035–1037.
Hoyt WF, Baghdassarian SA (1969) Optic glioma of childhood: natural history and rationale for conservative management. Br J Ophthalmol 53: 793–798.
Hrban RH, Shiu MH, Senie RT, Woodrun JM (1990) Malignant peripheral nerve sheath tumours of the but-tockand lower extremity. A study of 43 cases. Cancer 66:1253–1265.
Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG (2001) Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan trans-membrane heparan sulfate proteoglycans. J Neurosci 21: 3764–3770.
Hulsebos TJ, Bijleveld EH, Riegman PH, Smink LJ, Dumham I (1996) Identification and characterisation of NFl-related loci on human chromosomes 22, 14 and 2. Hum Gemet 98: 7–11.
Huson SM, Harper PS, Compston DAS (1988) Von Reck-linghausen neurofibromatosis: a clinical and population study in southeast Wales. Brain 111: 1355–1381.
Huson SM (1989) Recent developments in the diagnosis and management of neurofibromatosis type 1. Arch Dis Child 64: 745–749.
Huson SM, Compston DAS, Harper PS (1989a) A genetic study of von Recklinghausen neurofibromatosis in southeast Wales. 1: Guidelines for genetic counselling. J Med Genet 26: 712–721.
Huson SM, Compston DAS, Clark P, Harper PS (1989b) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26: 704–711.
Huson SM (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC (eds.) The neurofibromatosis: a pathogenic and clinical overview. London. Chapman and Hall Medical: 160–204.
Huson SM, Ruggie RAC (2006) The neurofibromatoses.In: pathogenetic and clinical overview. London: Chapman &Hall.
Huson SM, Ruggieri M (2006) The neurofibromatoses. In: Harper J, Oranje JM, Rose M (eds.) Textbook of paediatric dermatology. Oxford: Blackwell Science Publishers, pp. 1345–1385.
Il Teatro della Natura di Ulisse Aldrovandi (2001) Bologna: Editrice Compositori.
Illes T, Halmai V, de Jonge T, Dubousset J (2001) Decreased bone mineral density in eurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12: 823–827.
Ingordo V, D’Andria G, Mendicini S, Grecucci M, Baglivo A (1995) Segmental neurofibromatosis: is it uncommon or underdiagnosed? Arch Dermatol 131: 959–960.
Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiott K, New S, Hood A, Shannon K, Williams DA, Clapp DW (2001) Genetic and biochemical evidence that haploinsufficiency of the NF1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181–188.
Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAuley C, Lew WL (2004) A tiling resolution DNA microarray with complete coverage of the human genome. Nat Gen 36: 299–303.
Izawa I, Tamaki N, Saya H (1996) Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) CAMP-dependent protein kinase. FEBS Lett 382: 53–59.
Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA (1994) Tumor predisposition in mice heterozygous for a targeted mutation in Nfl. Nat Genet 7: 353–361.
Jacquemin C, Bosley TM, Liu D, Svedberg H, Buhalique A (2002) Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1. Am J Neuroradiol 23: 644–648.
Jadayel D, Fain O, Upadhyaya M, Ponder MA, Huson SM, Carrey J, Fryer A, Mathew CGP, Barker DF, Ponder BAJ (1990) Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature 343: 558–559.
Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffery S, Patton MA, Mariman E (1994) Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nature Genet 8: 357–360.
Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K (2005) The NF1 tumor suppressor critically regulates TSC2 and mTOR. PNAS 102: 8573–8580.
John A, Ruggieri M, Ferner R, Upadhyaya M (2000) A search for evidence of somatic mutation of the NF1 gene. J Med Genet 37: 44–49.
Johnson MR, Ferner RE, Bobrow M, Hughes RA (2000) Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 68: 643–646.
Kaefer M, Adams MC, Rink RC, Kaeting MA (1997) Principles in management in complex pediatric genitourinary plexiform neurofibroma. Urology 49: 936–940.
Kato M, Takashima S, Houdou S, Miyahara S (1995) Cerebellar leptomeningeal astroglial heterotopia in neurofibromatosis type 1. Clin Neuropathol 14:175–178.
Kaufmann D, Muller R, Bartelt B, Wolf M, Kunzi-Rapp K, Hanemann CO, Fahsold R, Hein C, Vogel W, Assum G (2001) Spinal neurofibromatosis without cafe-au-lait macules in two families with null mutations of the NF1 gene. Am J Hum Genet 69:1395–1400.
Kaufmann D, Muller R, Kenner O, Leistner W, Heim C, Vogel W, Bartlett B (2002) The N-terminal splice product NFl-10a-2 of the NF1 codes for a transmembrane segment. Biochim Biophys Res Commun 294: 496–503.
Kayes LM, Burke W, Riccardi VM, Bennet R, Ehrlich P, Rubenstein A, Stephens K (1994) Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 54: 424–436.
Kearse WS Jr, Ritchey ML (1993) Clitoral enlargement secondary to neurofibromatosis. Clin Pediatr 32: 303–304.
Kedar A (1997) Chemotherapy for pediatric brain tumors. Semin Pediatr Neurol 4: 320–332.
Kehrer-Sawatzki H, Schwickardt T, Assum G, Rocchi M, Krone W (1997) A third neurofibromatosis type 1 pseudogene at chromosome 15qll.2. Hum Genet 100: 595–600.
Kehrer-Sawatzki H, Assum G, Hameister H (2002) Molecular characterisation of t(17; 22)(q11.2; q11.2) is not consistent with NF1 gene duplication. Hum Genet 111: 465–467.
Kehrer-Sawatzki H, Tinschert S, Jenne DE (2003) Heterogeneity of breakpoints in constitutional deletions of the 17q11.2 NF1 tumour suppressor region. J Med Gen 40:116.
Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer M, Krammer U, Peyrl A, Jenne DE, Hansmann I, Mautner VF (2004) High Frequency of Mosaicism among Patients with Neurofibromatosis Type 1 (NF1) with Microdeletions Caused by Somatic Recombination of the JJAZ1 Gene. Am J Hum Genet 75: 410–423.
Keller RT, Logan GM Jr (1977) Adenocarcinoma of the pancreas associated with neurofibromatosis. Cancer 39: 1264–1266.
King AA, De Baun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Hum Genet 93: 388–392.
Kirsch M, Strasser J, Allende R, Bello L, Zhang JMP (1998) Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 58: 4654–4659.
Kluwe L, Friedrich RE, Peiper M, Friedman J, Mautner VF (2003) Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors. Hum Mutat 22: 420.
Korf BR (2002a) Clinical features and pathobiology of neurofibromatosis 1. J Child Neurol 17: 573–577.
Korf BR (2002b) Determination of end points for treatment of neurofibromatosis 1. J Child Neurol 17: 642–645.
Korf BR, Rubinstein A (2005) Neurofibromatosis type 1. A handbook for patients, families and health care professionals. Berlin: Thieme Publishing Group.
Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, Faingold R, Michovitz S, Kopiewitz B, Horev G (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. Am J Neuroradiol 22:1963–1969.
Kousseeff BG, Hoover DL (1999) Penile neurofibromas. Am J Med Genet 87:1–5.
Kuenzle C, Weissert M, Roulet E, Bode H, Schefer S, Huisman T, Landau K, Boltshauser E (1994) Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Neuropediatrics 25: 295–300.
Kulkantrakorn K, Geller TJ (1999) Seizures in neurofibromatosis type 1(NF1). Ped Neurol 19: 347–350.
Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J (2005) Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16: 928–936.
Kurien A, John PR, Mildford DV (1997) Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child 76: 454–455.
Kurtz A, Martuza RL (2002) Antiangiogenesis in Neurofibromatosis 1. J Child Neurol 17: 578–584.
Labardini MM, Kallet HA, Cerny JC (1968) Urogenital neurofibromatosis simulating an intersex problem. J Urol 98: 627–632.
Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, Frayling I, Efstathiou J, Pack K, Payne S, Roylance R, Gorman P, Sheer D, Neale K, Phillips R, Talbot I, Bodmer W, Tomlinson I (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson’s ‘two-hit’ hypothesis. Nat Med 5: 1071–1075.
Lammert M, Kappler M, Mautner VF, Lammert K, Storkel S, Friedman JM, Atkins D (2005) Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161–1166.
Largaespada DA, Brannan CI, Jenkins A, Copeland NG (1996) NF1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 12: 137–143.
Laue L, Comite F, Hench K, Loriaux L, Cutler GB, Pescovitz GH (1985) Precocious puberty associated with neurofibromatosis and optic gliomas. Am J Dis Child 139:1097–1100.
Lázaro C, Ravella A, Gaona A, Volpini V, Estiville X (1994) Neurofibromatosis type 1 due to germline mosaicism in a clinically normal father. New Engl J Med 331: 1403–1407.
Lázaro C, Gaona A, Ainsworth P, Tenconi R, Kruyer H, Ars E, Volpini V, Estivill X (1996) Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet 98: 696–699.
Lederman SM, Martin EC, Laffey KT, Lefkowith JH (1987) Hepatic neurofibromatosis malignant schwannoma and angiosarcoma in von Recklinghausen’s disease. Gastroenterology 92: 234–239.
Lee M, Rezai AR, Freed D, Epstein FJ (1996) Intramedullary spinal cord tumours in neurofibromatosis. Neurosurgery 38: 32–37.
Legius E, Marchuk DA, Hall BK, Anderson LB, Wallace MR, Collins FS, Glover TW (1992) NFl-related locus on chromosome 15. Genomics 13:1316–1318.
Legius E, Merchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat Genet 3:122–126.
Lehman WB, Atar D, Feldman DS (2000) Congenital pseudoarthrosis of the tibia. J Pediatr Orthop B 9: 153:107–109.
Lehrnebecher T, Gassel AM, Rauh V, Kirchner T, Huppertz HI (1994) Neurofibromatosis presenting a severe systemic vasculopathy. Eur J Pediatr 153:107–109.
Les Oeuvres d’Ambroise Parè (1585) Conseiller et premier Chirurgien du Roy. Divisèes en vingt huit Livres. Avec les figures et portraicts, tant de l’Anatomie, que des instruments de Chirurgie, et de plusiers Monstres..... A Paris, chez Gabriel Buon.
Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275–281.
Li Y, O’Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, Neil S, Robertson M, White R, Viskochil D (1995) Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25: 9–18.
Li C, Cheng Y, Gutmann DA, Mangoura D (2001) Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev 130: 231–248.
Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JE (2002) Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1: p53 mouse tumor model. Cancer Res 62: 4507–4513.
Lipton S, Zuckerbrod M (1966) Familial enteric neurofibromatosis. Med Times 94: 544–548.
Listernick R, Charrow J, Greenwald MJ, Sterly NB (1989) Optic gliomas in children with neurofibromatosis type l. J Pediatr 114: 788–799.
Listernick R, Darling C, Greenwald M, Strauss L, Charrow J (1995) Optic pathway in children. The effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 127: 718–722.
Listernick R, Louis DN, Packer RJ, Gutman DH (1997) Optic pathways gliomas in children with neurofibromatosis type 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41: 143–149.
Listernick R, Charrow J, Gutmann DH (1999) Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89: 38–44.
Listernick R, Gutman DH (1999) Tumors of optic pathway: In: Friedman JM, Gutman DH, Mc Collin M, Riccardi VM (eds.) Neurofibromatosis. Phenotype, natural history and pathogenesis. Baltimore and London: The John Hopkins University Press, pp. 203–230.
Listernick R, Mancini AJ, Charrow J (2003) Segmental neurofibromatosis in childhood. Am J Med Genet A 121: 132–135.
Listernick R, Ferner R, Piersall L, Sharig S, Gutmann DH, Charrow J (2004) Late onset optic pathway tumours in children with neurofibromatosis 1. Neurology 63: 1944–1946.
Listernick R, Charrow J (2004a) Knowledge without truth: screening for complications of neurofibromatosis type 1 in childhood. Am J Med Genet 127A: 221–223.
Listernick R, Charrow J (2004b) Neurofibromatosis type 1 in childhood. Adv Dermatol 20: 75–115.
Liu GT, Lesseil S (1992) Spontaneous visual improvement in chiasmal gliomas. Am J Ophthalmol 114: 193–201.
Lopez-Correa C, Dorscher M, Brems H, Lazaro C, Clementi M, Upadhyaya M, Dooijes D, Moog U, Kehrer-Sawatzki H, Rutkowski JL, Fryns JP, Marynen P, Stephens K, Legius E (2001) Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 10:1387–1392.
Luijten M, Redeker S, van Noesel MM, Troost D, Westveld A, Hulsebos TJ (2000a) Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas. Eu J Hum Genet 8: 939–949.
Luijten M, Wang Y, Smith BT, Westerveld A, Smink LJ, Dunham I, Roe BA, Hulsebos TJ (2000b) Mechanism of spreading of highly related neurofibromatosis type 1 (Nf1) pseudogenes on chromosome 2, 14 and 22. Eur J Hum Genet 8: 209–214.
Luijten M, Redeker S, Minoshima S, Shimizu N, Westerveld A, Hulsebos T (2000c) Duplication and transposition of the NF1 pseudogene regions on chromosomes 2, 14, and 22. Hum Gen 109:109–116.
Luijten M, Fahsold R, Mischung C, Westerveld A, Nürnberg P, Hulsebos TJM (2001) Limited contribution of interchromosomal gene conversion to NF1 gene mutation. J Med Genet 38: 481–485.
Luria D, Avigad S, Cohen IJ, Stark B, Weitz R, Zaizov R (1997) p53 mutation as the second event in juvenile chronic myelogenous leukaemia in a patient with neurofibromatosis type 1. Cancer: 2013–2018.
Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, Wever I, Vermeesch JR, de Raedt T, Paepe A, Speleman F, Oosterom A, Messiaen L, Legius E (2006) Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Human Mol Genet 15:1015–1023.
Macaluso M, Russo G, Cinti C, Bazan V, Gebbia N (2002) A Ras family genes: an interesting link between cell cycle and cancer. J Cellular Phys 192: 125–130.
MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, Lev M, Mautner VF, Niimura M, Plotkin SR, Sang CN, Stemmer-Rachamimov A, Roach ES. Diagnostic criteria for schwannomatosis. Neurology 64:1838–1845.
Madigan P, Masello MJ (1989) Report of a neurofibromatosis-like case: Monstrorum Historia, 1642. Neurofibromatosis 2: 53–56.
Magro G, Piana M, Venti C, Lacagnina A, Ruggieri M (2000) Solitary neurofibroma of the mesentery: report of a case and review of the literature. Pathol Res Pract 196: 713–718.
Mallmann R, Roth FJ (1986) Treatment of neurofibromatosis associated renal artery stenosis with hypertensión by percutaneous transluminal angioplasty. Clin Exp Hypertens 8: 893–899.
Manoli A, Potter RT, Perfetto J, Coleman A (1969) Thoracic manifestations of Recklinghausen’s disease. NY State J Med 69: 3014–3018.
Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchell AL, Gutmann DH, Boguski M, Collins FS (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of NF1 gene product. Genomics 11: 931–940.
Marchuk DA, Tavakkol R, Wallace MR, Brownstein BH, Taillon-Miller P, Fong CT, Legius E, Anderson LB, Glover TW, Collins FS (2001) A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene. Genomics 13: 672–680.
Maria B (2002) Neurofibromatosis. J Child Neurol 17: 547–653.
Maris JM, Wiersma SR, Mahgoub N, Thomson P, Geyer J, Hurwitz CG, Lange BJ, Shannon KM (1997) Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Cancer 79:1438–1446.
Martin-Gallardo A, Tarie SA, Freedman M, Wilson-Gunn S, Bernards A, Collins FS (1994) DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. Genomics 3: 649–652.
Masip MJ, Esteban E, Alberto C, Menor F, Cortina H (1996) Laryngeal involvement in pediatric neurofibromatosis: a case report and review of the literature. Pediatr Radiol 26: 488–492.
Mautner VF, Friedich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R, Funsterer C (2003) Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MR1 supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45: 618–625.
Mc Donnell CH (1936) Neurofibromatosis of the bladder and prostate. Amer J Surg 34: 90.
Mc Gaughran JM, Harris DI, Donnai D, Teare D, Me Leod R, Westerbeek R et al. (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197–203.
Mc Grath PC, Sloan DA, Schwartz RW, Kenady DE (1998) Advances in the diagnosis and treatment of adrenal tumors. Curr Opin Oncol 10: 52–57.
Mc Keen EA, Bodurtha J, Meadows AT, Douglas EC, Mulvihill JJ (1978) Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr 93: 992–993.
Mcfarlane R, Levin AV, Wekswerg R, Blaser S, Rutka JT (1995) Absence of the greater sphenoid wing in neurofibromatosis type 1: congenital or acquired: case report. Neurosurgery 37:129–133.
Meadows AT, D’Angio GF, Mike V, Banfi A, Harris C, Jenkin RDT, Schwartz A (1977) Pattern of second malignant neoplasms in children. Cancer 40: 1903–1911.
Meinecke P (1987) Evidence that the neurofibromatosis-Noonan syndrome is a variant of von Recklinghausen neurofibromatosis. Am J Med Genet 26: 741–745.
Menko FH, Kaspers GL, Meijer GA, Claes K, van Hagen JM, Gille JJ (2004) A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer 3:123–127.
Messiaen L, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 955 of mutations and reveals a high frequency of unusual splicing defects. Hum Mut 15: 541–555.
Messiaen L, Riccardi V, Peltonen J, Maertens O, Callens T, Karvonen SL, Leisti EL, Koivunen J, Vandenbroucke I, Stephens K, Poyhonen M (2003) Independent NF1 mutations in two large families with spinal neurofibromatosis. J Med Genet 40:122–126.
Miller SJ, Li H, Rizvi TA, Huang Y, Johansson G, Bowersock J, Sidani A, Vitullo J, Vogel K, Parysek LM, DeClue JE, Ratner N (2003) Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol 23:2213–2224.
Molloy PT, Bilaniuk LT, Vaughan SN, Needle MN, Lin GT, Zackai EH, Phillips PC (1995) Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 45:1897–1902.
Moore BD III, Slopis JM, Jackson FF, De Winter AE, Leeds NE (2000) Brain volume in children with neurofibromatosis type 1. Relation to neuropsychological status. Neurology 54: 914–920.
Morse RP (1999) Neurofibromatosis type 1. Arch Neurol 6: 364–365.
Moss C, Green SH (1994) What is segmental neurofibromatosis? Br J Dermatol 130:106–110.
Motte J, Billard C, Fejerman N, Sfaello Z, Arroyo H, Dulac O (1993) Neurofibromatosis type 1 and west syndrome: a relatively benign association. Epilepsia 34: 723–726.
Mulvihill JJ (1988) Neurofibromatosis: history, nomenclature, and natural history. Neurofibromatosis 1(2): l45:575–578.
National Institutes of Health Consensus Development Conference Statement (1988) Neurofibromatosis. Arch Neurol 45: 575–578.
Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S, Sutton LN, Vaughan SN, Zackai EH, Zhao H, Molloy PT (1997) Prognostic signs in the surgical management of plexiform neurofibroma-The Children’s Hospital of Philadelphia experience, 1974-1994. J Pediatr 131: 678–682.
Negoro M, Nakaya T, Terashima K, Sugita K (1990) Extracranial vertebral artery aneurysm with neurofibromatosis. Neuroradiology 31: 533–536.
North K (1993) Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol 8: 395–402.
North K, Cochineas C, Tang E, Fagan E (1994) Optic gliomas in neurofibromatosis type 1: role of evoked potentials. Pediatr Neurol 10:117–123.
North K (1997) Neurofibromatosis type 1 in childhood. International Review of Child Neurology Series. London: McKeith, pp. 36.
North KN, Riccardi VM, Samango-Sprouse C et al. (1997) Cognitive function and academic performance in neurofibromatosis type 1. Neurology 48:1121–1127.
North K (2000) Neurofibromatosis type 1. Am J Med Genet (Sem Med Genet) 97:119–127.
North K, Hyman S, Barton B (2002) Cognitive deficits in neurofibromatosis 1. J Child Neurol 17: 605–612.
Norton KK, Xu J, Gutmann DH (1995) Expression of the neurofibromatosis 1 gene product, neurofibromin, in blood vessels, endothelial cells and smooth muscle. Neurobiol Dis 2:13–21.
Ogawa A, Watanabe K (1986) Genitourinary neurofibromatosis in a child presenting with enlarged penis and scrotum. J Urol 135: 755–757.
Ogawa T, Mitsukawa T, Ishikawa T, Tamura K (1994) Familial pheochromocytoma associated with von Reck-linghausen’s disease. Int Med 33:110–114.
Oguzkan S, Cinbis M, Ayter S, Anlar B, Aysun S (2004) Familial segmental neurofibromatosis. J Child Neurol 19: 392–394.
Opitz JM, Weaver DD (1985) The neurofibromatosis-Noonan syndrome. Am J Med Genet 21: 477–490.
Osborn M, Cooper DN, Upadhyaya M (2001) Molecular analysis of the 5’-flanking region of the neurofibromatosis type 1(NF1) gene: identification of five sequence variants in NF1 patients. Clin Genet 57:221–224.
Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86: 747–754.
Packer RJ, Rosser T (2002) Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview. J Child Neurol 17: 638–641.
Packer RJ, Gutmann DH, Rubenstein A, Viskochil D, Zimmerman RA, Vezina G, Small J, Korf B (2002) Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology 58:1461–1470.
Parazzini C, Triulzi F, Bianchini E, Agnetti V, Conti M, Zanolini C, Maninetti MM, Rossi LN, Scotti G (1995) Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evolution. Am J Neurorradiol 16:1711–1719.
Parizel PM, Martin JJ, Van Vyve M, van den Hauwe L, De Schepper AM (1991) Cerebral ganglioglioma and neurofibromatosis type 1. Case report and review of the literature. Neuroradiology 33: 357–359.
Park VM, Kenwright KA, Sturtevant DB, Pivmick EK (1998) Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene. Hum Genet 103: 382–385.
Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro ML, McFadzean RM, Rubtsova IV, Hoyt WF (2001) Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 119: 516–529.
Partington MW, Burggraf GW, Fay JE, Frontini E (1985) Pulmonary stenosis, cafe au lait spots and dull intelligence: the Watson syndrome revisited. (Abstract) Proc Greenwood Genet Center 4:105.
Pascual-Castroviejo I, Velez A, De la Cruz Medina M, Verdu A, Villarejo F, Pèrez-Higueras A (1986) Neurofibromatosis y tumores del sistema nervioso central. Neurologia 1: 6–10.
Pascual-Castroviejo I, Verdú A, Román M, De la Cruz-Medina M, Villarejo F (1988) Optic glioma with progressive occlusion of the aqueduct of Sylvius in monozygotic twins with neurofibromatosis. Brain Dev 10: 24–29.
Pascual-Castroviejo I (1992) Complications of neurofibromatosis type 1 in a series of 197 children. In: Fukuyama Y, Suzuki Y, Kamoshita S, Casaer P (eds.) Fetal and perinatal neurology. Basel: Karger, pp. 162–173.
Pascual-Castroviejo I, Martinez Bermejo A, Lopez Martìn V, Roche C, Pascual-Pascual SI (1994) Optic gliomas in neurofibromatosis type 1 (NF1). Presentation of 31 cases. Neurologia 9:173–177.
Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J, Martinezì V (2000) Generalized nerve sheath tumors in neurofibromatosis type 1 (NF1). A case report. Neuropedi-atrics 31: 211–213.
Pascual-Castroviejo I, Pascual-Pascual SI, Rafia S (2001) Tumores. In: Pascual-Castroviejo I (ed.) Neurofibromatosis. Madrid: Escuela Libre Editorial, pp. 133–182.
Pascual-Castroviejo I (2001b) Estenosis del acueducto de Silvio. In: Pascual-Castroviejo I (ed.) Neurofibromatosis. Madrid: Escuela Libre Editorial, pp. 66–70.
Pascual-Castroviejo I (2001b) Sìndrome de dèficit de atenciön con hiperactividad (SDAHA). In: Pascual-Castroviejo I (ed.) Neurofibromatosis. Madrid: Escuela Libre Editorial, pp. 198–199.
Pascual-Castroviejo I, Cortés P, Fernández-Cuadrado J, De la Flor-Crespo M, Pascual-Pascual SI (2002) Hemangioma cutáneo asociado a hemangioma hepático y neurofibromatosis tipo 1 (NF1). Rev Neurol 34: 652–654.
Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Botella P, Viano J. (2007) Familial spinal neurofibromatosis. Neuropediatrics 38:105–108.
Payne MS, Nadell JM, Lacassie Y, Tilton AH (2003) Congenital glaucoma and neurofibromatosis in a monozygotic twin: case report and review of the literature. J Child Neurol 18: 504–508.
Peltonen J, Jaakola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1998) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59: 760–771.
Pennybacker J (1940) Stenosis of the aqueduct of Sylvius. Proc R Soc Med 33: 507–512.
Perez-Grueso FJ (2001) La columna vertebral en la neurofibromatosis. In: Pascual-Castroviejo I (ed.) Neurofibromatosis. Madrid: Escuela Libre Editorial, pp. 113–120.
Perrin RG, Guha A (2004) Malignant peripheral nerve sheath tumors. Neurosurg Clin N Am 15: 203–216.
Pierce SM, Barnes PD, Loeffler JS, McGinn C, Tarbeil NJ (1990) Definitive radiation therapy in the management of symptomatic patients with optic glioma. Cancer 65: 4–29.
Pilmore HL, Nagara MP, Walker RJ (1997) Neurofibromatosis and renovascular hypertension presenting in early pregnancy. Nephrol Dial Transplant 12: 184–187.
Pohymen M, Leisti EL, Kytola S, Leisti J (1997) Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet 34:184–187.
Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652–1660.
Poole MD (1989) Experiences in the surgical treatment of cranio-orbital neurofibromatosis. Br J Plast Surg 42: 155–162.
Pou Serradell A (1983) Hidrocefalia no-tumoral y neurofibromatosis. Rev Neurol 11:231–255.
Poyhonen M, Leisti EL, Kytola S, Leisti J (1997) Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet 37: E43.
Poyhonen M (2000) A clinical assessment of neurofibromatosis type 1 (NF1) and segmental NF in Northern Finland. J Med Genet 37: E43.
Pulst SM, Riccardi VM, Fain P, Korenberg JR (1991) Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology 41:1923–1927.
Purandare S, Cawthon R, Nelson LM, Sawada S, Watkins WS, Ward K, Jorde LB, Viskochil DH (1996) Genotyping of PCR based polymorphisms and linkage-disequilibrium analysis at the NF1 locus. Am J Hum Genet 59:159–166.
Quattrin T, McPherson E, Putnam T (1987) Vertical transmission of the neurofibromatosis/Noonan syndrome. Am J Med Genet 26: 645–649.
Raffel C, McComb JG, Bodner S, Gilles FE (1989) Benign brainstem lesions in pédiatric patients with neurofibromatosis: case report. Neurosurgery 25: 959–964.
Rasmusen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151: 33–40.
Rasmusen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68:1110–1118.
Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT, Smith CD, Tsang S, Munroe DJ, Jacks T (2004) Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. PNAS 101(35): 13008–13013.
Riccardi VM (1982) Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 7: 1–34.
Riccardi VM (1987) Neurofibromatosis. In: Gomez MR (ed.) Neurocutaneous diseases. A practical approach. Stoneham: Butterworths, pp. 11–29.
Riccardi VM (1992) Neurofibromatosis. Phenotype, natural history, and pathogenesis, 2nd ed. Baltimore-London: The Johns Hopkins University Press.
Ricciardone MD, Ozcelik T, Cevher B, Ozdag H, Tuncer M, Giirgey A, Uzunalimoglu O, Cetinkaya H, Tanyeli A, Erken E, Oztiirk M (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. JEur Aca d Dermatol
Richetta A, Giustini S, Recupero SM, Pezza M, Carlomagno V, Amoruso G, Calvieri S (2004) Lisch nodules of the iris in neurofibromatosis type 1. J Eur Acad Dermatol Venereol 18: 342–344.
Rink RC, Mitchell MR (1983) Genitourinary neurofibromatosis in childhood. J Urol 130:1176–1179.
Rodenhiser DI, Andrews JD, Mancini DN, Jung JH, Singh SM (1997) Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene. Mutat Res 373:185–195.
Rodriguez FJ, Perry A, Gutmann DH, O’Neill BP, Leonard J, Bryant S, Giannini C (2008) Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 67: 240–249.
Rosenbaum T, Rosenbaum C, Winner U, Müller HW, Lenard H-G, Hanemann CO (2000) Long-term culture and characterization of human neurofibroma-de-rived Schwann cells. J Neuro Res 61: 524–531.
Rosser T, Packer RJ (2002) Intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol 17: 630–637.
Rubenstein A, Bader JL, Aron AA, Wallace S (1983) Familial transmission of segmental neurofibromatosis. Neurology 33(Suppl 2): 76 (Abstract).
Ruggieri M (1999) The different forms of neurofibromatosis. Child’s Nerv Syst 15: 295–308.
Ruggieri M, Huson SM (1999) The neurofibromatoses. An overview. Ital J Neurol Sci 20: 89–108.
Ruggieri M, Pavone V, De Luca D, Franzo A, Tinè A, Pavone L (1999) Congenital bone malformations in patients with neurofibromatosis type 1. J Pediatr Orthop 19: 301–305.
Ruggieri M, Dárrigo G, Abate M, Distéfano A, Upadhyaya M (2000) Multiple coronary artery aneurysms in a child with neurofibromatosis type 1. Eur J Pediatr 159: 178–180.
Ruggieri M (2001) Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 101: 178–180.
Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433–1443.
Ruggieri M, Packer J (2001) Why do benign astrocytomas become malignant in NF1? Neurology 56: 827–829.
Ruggieri M, Polizzi A (2003) From Aldrovandi’s Homuncio (1592) to Buffon’s girl (1749) and the Wart Man of Tilesisus (1793): antique illustrations of mosaicism in neurofibromatosis? J Med Genet 40: 227–232.
Ruggieri M, Pavone P, Polizzi A, Di Pietro M, Scuderi A, Gabriele A, Spalice A, Iannetti P (2004) Ophthalmo-logical manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol 88:1429–1433.
Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36: 21–34.
Ruggieri M, Iannetti P, Clementi M, Polizzi A, Incorpora G, Spalice A, Elia M, Gabriele A, Tenconi R, Pavone L (2008) Neurofibromatosis type 1 and infantile ria (in press).
Ruggieri M, Mastrangelo M, Spalice A, Mariani R, Bottillo I, Torrente I, Iannetti P (2008) A further case of Neurofibromatosis type 1 and polymicrogyria (in press).
Ruggieri M, Upadhyaya M, Pascaul-Castroviejo I (2008) The different forms of neurofibromatosis: update 2008 (in press).
Sabah MM, Cummins RBS, Leader MF, Kay EF (2006) Loss of pl6INK4A expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected malignant peripheral nerve sheath tumors. Appl Immunohistochem M M 14: 97–102.
Sadun F, Hinton DR, Sadun AA (1996) Rapid growth of optic nerve ganglioglioma in a patient with neurofibromatosis 1. Ophthalmology 103: 794–799.
Sajid MH, Copple PJ (1968) Familial aqueductal stenosis and basilar impression. Neurology 18: 260–262.
Salyer WR, Salyer DC (1974) The vascular lesion of neurofibromatosis Angiology 2: 6–22.
Samuelson B, Samuelson S (1989) Neurofibromatosis in Gothenburg. Sweden. I. Background, study design and:pects. Neurofibromatosis 2: 6–22.
Samuelson B, Riccardi VM (1989) Neurofibromatosis in Gothenburg. Sweden. III. Psychiatric and social aspects. Neurofibromatosis 2: 84–106.
Sarkozy A, Schirinzi A, Lepri F, Bottillo I, De Luca A, Pizzuti A, Tartaglia M, Digilio MC, Dallapiccola B (2007) Clinical lumping and molecular splitting of LEOPARD and NF1/NF1-Noonan syndromes. Am J Med Genet A 143:1009–1011.
Savasan S, Smith L, Scheer C, Dansey R, Abella E (2005) Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1. Pediatr Transplant 9: 534–536.
Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D (1996) Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 14: 110–112.
Scheffzek K, Lautwein A, Kabsch W, Ahmadian MR, Wittinghofer A (1999) Crystal structure of the GT-Pase-activating domain of human pl20GAP and implications for the interaction with Ras. Nat 384: 591–596.
Schievink WI, Riedinger M, Maya MM (2005) Frequency of incidental intracranial aneurysms in neurofibromatosis type 1. Am J Med Genet 134A: 45–48.
Schindeler A, Little DG (2008) Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1). Bone 42: 616–622.
Schorry EK, Crawford AH, Egelhoff JC, Lovell AM, Saal HM (1997) Thoracic tumors in children with neurofibromatosis 1. Am J Med Genet (Neuropsychiatr Genet) 74: 533–537.
Segal R (1993) Segmental neurofibromatosis of the sciatic nerve: case report. Neurosurgery. 33: 948.
Serra E, Plug S, Otero D, Gaons A, Kruyer H, Ars E, Estivill X, Lazaro C (1997) Confirmation of a doublehit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 51: 512–519.
Serra E, Rosenbaum T, Winner U, Aldeo R, Ars E, Estivill X, Lenard HG, Lazaro C (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two Schwann cells subpopulations. Hum Mol Genet 9: 3055–3084.
Serra E, Ars E, Ravella A, Sanchez A, Puig S, Rosenbaum T, Estivill X, Lazaro C (2001a) Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Hum Genet 108: 416–429.
Serra E, Rosenbaum T, Nadal M, Winner U, Ars E, Estivill X, Lazaro C (2001b) Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet 28:294–296.
Shannon KM, Watterson J, Johnson P, O’Connell P, Lange B, Shah N et al. (1992) Monosomy 7 myeloprolipherative disease in children with neurofibromatosis type 1: epidemiology and molecular analysis. Blood 79: 1311–1318.
Shannon KM, O’Connel P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330: 597–601.
Silva AJ, Franckland PW, Marowitz Z, Friedman E, Laszlo GS, Cioffi D, Jacks T, Bourtchuladze R (1997) A mouse model for the neurological deficits associated with neurofibromatosis type 1. Nature Genet 15: 281–284.
Singh K, Samartzis D, An HS (2005) Neurofibromatosis type I with severe dystrophic kyphoscoliosis and its operative management via a simultaneous anterior-posterior approach: a case report and review of the literature. Spine J 5: 461–466.
Sobata E, Ohkuma H, Suzuki S (1988) Cerebrovascular disorders associated with von Recklinghausen’s neurofibromatosis: a case report. Neurosurgery 22: 544–549.
Sorensen SA, Mulvihihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314: 1010–1015.
Specht CS, Smith TW (1988) Uveal malignant melanoma and von Recklinghausen’s neurofibromatosis. Cancer 62: 812–817.
Stay EJ, Vawter G (1977) The relationship between neuroblastoma and neurofibromatosis (von Recklinghausen’s disease) Cancer 39:2250–2255.
Stephens K, Kayes L, Riccardi VM, Rising M, Sybert VP, Pagon RA (1992) Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet 88: 279–282.
Stevenson DA, Viskochil DH, Rope AF, Carey JC (2006a) Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet 69: 246–253.
Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D’Astous JL, Santora SD, Viskochil DH (2006b) Double inactivation of NF1 in tibial pseudoarthritis. Am J Hum Genet 79:143–148.
Stevenson DA, Moyer-Mileur LJ, Murray M, Slater H, Sheng X, Carey JC, Dube B, Viskochil DH (2007) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 150: 83–88.
Suh JS, Abenoza P, Galloway HR, Everson LI, Griffiths HJ (1992) Peripheral (extracranial) nerve tumors: correlation of MR imaging and histology findings. Radiology 183: 341–346.
Sutphen R, Galán-Gómez E, Kousseff BG (1995) Clitoromegaly in neurofibromatosis. Am J Med Genet 55: 325–330.
Suzuki V, Suzuki H, Kayama T et al. (1991) Brain tumours predominantly express NF1 gene transmembrane containing the 63 base in the region coding for GTPase activating protein related domain. Biochem Biophys Res Commun 181: 955–961.
Suzuki H, Takahashi K, Kubota Y, Shibahara S (1992) Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein. Biochem Biophys Res Commun 187: 984–990.
Suzuki H, Ozawa N, Taga C, Kano T, Hattori M, Sakati Y (1994) Genomic analysis of a NFl-related pseudogene on human chromosome 21. Gene 147: 247–250.
Szudek J, Birch SJ, Friedman JM (2000) The national neurofibromatosis foundation international database participants. Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 37: 933–938.
Szudek J, Joe H, Friedman JM (2002) Analysis of intrafamilial phenotypic variation in neurofibromatosis type 1 (NF1). Genet Epidemiol 23:150–164.
Taboada D, Alonso A, Moreno J, Muro D, Mulas F (1979) Occlusion of the cerebral arteries in Recklinghausen’s disease. Neuroradiology 18: 281–284.
Takamiya Y, Friendlander RM, Brem H, Malick A, Martuza RL (1993) Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J Neurosurg 78: 470–476.
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29: 465–468.
Tartaglia M, Niemeyer CM, Shannon KM, Loh ML (2004a) SHP-2 and myeloid malignancies. Curr Opin Hematol 11: 44–50.
Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A. (2004b) Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood 104: 307–301.
Tashiro K, Nakagawa T, Ito T (1975) An autopsy case of Von Recklinghausen’s disease with aqueductal occlusion due to septum formation and gliosis associated with subtentorial cyst formation (in Japanese). No To Shinkei 27: 333–342.
Tega W (2002) Guide to Palazzo Poggi Museum. Science and Art. Bologna: Editrice Compositori, pp. 18–25.
Tenny RT, Laws ER Jr, Younge BR, Rush JA (1982) The neurosurgical management of optic glioma. Results in 104 patients. J Neurosurg 57: 452–458.
The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Guesella JF, Harriharan IK, Bernards A (1997) Rescue of a Drosophila NF1 mutant by protein kinase A. Science 276: 791–794.
Thomas PK, King RHM, Chiang TR, Scaravalli F, Sharma AK, Downie AW (1990) Neurofibromatosis neuropathy. Muscle Nerve 13: 93–101.
Thomson PD, Harty YI, Köper D (1992) Neurofibroma of the penis. Urology 40: 555–556.
Thomson SA, Wallace MR (2002) RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 110: 495–502.
Tilesius von Tilenau WG (1793) Historia pathologica singularis Cutis Turpitudinis: Jo Gondofredi Rheinardi viri Lannorum. Leipzig: Germanny, SL Crusius.
Tinschert W, Holdener EE, Haertel MM, Senn H, Vetter W (1985) Secondary hypertension and neurofibromatosis: bilateral renal artery stenosis and coarctation of the abdominal aorta. Klin Wochens 63: 593–596.
Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne DE (2000) Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 8: 455–459.
Tomsick TA, Lukin RR, Chambers AA, Benton C (1976) Neurofibromatosis and intracranial arterial occlusive disease. Neuroradiology 11: 229–234.
Tong J, Hannan F, Zhu Y, Bernards A, Zhong Y (2002) Neurofibromin regulates G protein stimulating adenylyl cyclase activity. Nat Neurosci 5: 95–96.
Tortori-Donati P, Rossi A, Biancheri R, Andreula CF (2005) Phakomatoses. In: Tortori-Donati P (ed.) Pediatric neuroradiology. Brain. Berlin New York Springer, pp. 763–818.
Tow SL, Chandela S, Miller NR, Avellino AM (2003) Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28: 262–270.
Traub JA, O’Connor W, Masso PD (1999) Congenital pseudoarthrosis of the tibia: a retrospective review. J Pediatr Orthop 19: 735–738.
Tudisco C, Bollini C, Dungel P (2000) Functional results at the end of skeletal growth in 30 patients affected by congenital pseudoarthrosis of the Tibia. J Pediatr Orthop 9: 94–102.
Uhlin SR (1980) Segmental neurofibromatosis. South Med J 73: 526–567.
Upadhyaya M, Sarfarazi M, Broadhead W, Huson SM, Allanson J, Fryer AE, Harper PS (1989) Linkage of Watson’s syndrome to chromosome 17 markers. (Abstract) Cytogenet Cell Genet 51:1094.
Upadhyaya M, Sarfarazi M, Huson S, Broadhead W, Allanson J, Fryer A, Harper PS (1990) Linkage of Watson’s syndrome to chromosome 17 markers. (Abstract) J Med Genet 27: 209.
Upadhyaya M, Shen M, Cherryson A, Farnham J, Maynard J, Huson SM, Harper PS (1992) Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum Molec Genet 1: 735–740.
Upadhyaya M, Cooper DN (1998a) Neurofibromatosis type 1. From genotype to phenotype. Oxford: Bios Scientific Publishers.
Upadhyaya M, Cooper DN (1998b) The mutational spectrum in neurofibromatosis type 1 and its underlying mechanisms. In: Upadhyaya M, Cooper DN (eds.) NF1: from genotype to phenotype. Oxford: BIOS Publishers.
Upadhyaya M, Shaw DJ, Harper PS (1994) Molecular basis of neurofibromatosis typel (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum Mutation 4: 83–101.
Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S, Penttinen M, Cordeiro A, Ponder M, Ponder B, Krawczak M, Cooper DN (1998) Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 102: 591–597.
Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper DN (2003) Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1. Hum Genet 112:12–17.
Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas N, Potts C, Griffiths S, Ruggieri M, von Deimling A, Cooper DN (2004) Characterisation of somatic mutational spectrum of neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumours. Hum Mut 23: 134–146.
Upadhyaya M, Spurlock G, Majounie E, Griffiths S, Forrester N, Baser M, Huson SM, Evans G, Ferner R (2006) The heterogeneous nature of germlinemutations in NF1 patients with malignant peripheral nerve sheath tumours (MPNSTs). Hum Mut 27: 716.
Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L. (2007) An absence of cutaneous neurofibroma associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970_2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 80(1): 140–151.
Vandenbroucke I, Doom R, Callens, T, Cobben J, Starink T, Messiaen L (2004) Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet 114:284–290.
Verhest A, Verschraegen J, Grosjean W, Heimann R (1981) Transmissible chromosome abnormality in familial intestinal neurofibromatosis. (Abstract) Sixth Int. Cong. Hum. Genet., Jerusalem, p. 176.
Verhest A, Verschraegen J, Grosjean W, Draps JP, Vamos E, Heimann R, Hecht F (1988) Hereditary intestinal neurofibromatosis. II. Translocation between chromosomes 12 and 14. Neurofibromatosis 1: 33–36.
Viskochil D, Carey JC (1992) Nosological considerations of the neurofibromatosis. J Dermatol 19: 873–880.
Viskochil D, Carey J (1994) Alternate and related forms of neurofibromatosis. In The Neurofibromatoses: A Pathogenic and Clinical Overview. Eds S Huson and R Hughes, Chapman and Hall Medical, p. 445.
Viskochil, DH (1998) Gene structure and function. In Neurofibromatosis Type 1: From Genotype to Phenotype (Upadhyaya, M.A.C., ed.), 39–56, BIOS Scientific Publications Limited.
Vivarelli R, Grosso S, Calabrese F, Farnetani M, Di Bartolo R, Morgese G, Balestri P (2003) Epilepsy in neurofibromatosis 1. J Child Neurol 18: 338–342.
Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parade LF (1999) Mouse tumor model for neurofibromatosis type 1. Science 286: 2176–2179.
Von Deimling A, Krone W, Menon AG (1995) Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5:153–162.
Waldassen FV (1998) Foundation Library. Passau: Peda-Kunstfuhrer.
Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Seulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181–186.
Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E, Puisieux A (1999) Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 59: 294–297.
Wang Q, Montmain G, Ruano E, Upadhyaya M, Dudley S, Liskay MR, Thibodeau SN, Puisieux A (2003) The neurofibromatosis type 1 gene as a mutational target in mismatch repair-deficient cells. Hum Genet 112: 117–123.
Watson GH (1967) Pulmonary stenosis, cafe-au-lait spots, and dull intelligence. Arch Dis Child 42: 303–307.
Weinberg RA (1991) Tumor suppressor genes. Science 254: 1138–1146.
Whiteside D, McLeod R, Graham G, Steckley JL, Booth K, Somerville MJ, Andrew SE (2002) A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple caféau-lait spots. Cancer Res 62: 359–362.
Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, Gillespie A, Whitcomb P, Palumbo JS, Pitney A, Jayaprakash N, Zannikos P, Balis FM (2006) Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol 24: 507–516.
Wiest V, Eisenbarth I, Schmegner C, Krone W, Assum G (2003) Somatic NF1 mutation spectra in a family with neurofibromatosis type 1 toward a theory of genetic modifiers. Hum Mutat 22: 423–427.
Wimmer K, Eckart M, Stadler PF, Rehder H, Fonatsch C (2000) Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type 1 patients. Hum Mutat 16: 90–91.
Wimmer K, Muhlbauer M, Eckart M, Callens T, Rehder H, Birkner T, Leroy JG, Fonatsch C, Messiaen L (2002) A patient severely affected by spinal neurofibromas carries a recurrent splice site mutation in the NF1 gene. Eur J Hum Genet 10: 334–338.
Wittkower R (1942) Marvels of the East. A study in the history of monsters. Warburg Courtauld Inst 5: 159.
Witzleben CL, Landy RA (1974) Disseminated neuroblastoma in a child with von Recklinghausen disease. Cancer 34: 786–790.
Woodruff JM, Perino G (1994) Non-germ cell or teratomateus malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Sem Diagn Surg Pathol 11: 69–81.
Woodruff JM (1999) Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet (Sem Med Genet) 89: 23–30.
Wolkenstein P, Freche B, Zeller J, Revuz J (1995) More on the frequency of segmental neurofibromatosis. Arch Dermatol 131:1465.
Wolkenstein P, Freche B, Zeller J, Revuz J (1996) Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. Arch Dermatol 132: 1333–1336.
Wu BL, Boles RG, Yaari H, Weremowicz S, Schneider GH, Korf BR (1997) Somatic mosaicism for deletion of the entire NF1 gene identified by FISH. Hum Genet 99: 209–213.
Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471–484.
Xu GF, O’Connell P, Viskochil DH, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, et al (1990a) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599–608.
Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F (1990b) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63: 853–841.
Xu GF, Mulligan LM, Ponder MA, Llu L, Smith BA, Mathew CG, Ponder BA (1992) Loss of NF1 alleles in phaeochromocytomas form patients with type 1 neurofibromatosis. Genes Chromosome Cancer 4: 337–342.
Yang KH, Rim H, Cho OK, Ko BH (2002) Segmental colonic involvement of plexiform neurofibroma in neurofibromatosis type 1. J Comp Assist Tomogr 26: 129–131.
Yang FC, Ingram DA, Chen S, Hingtgen CM, Ratner N, Monk KR, Clegg T, White H, Mead L, Wenning MJ, Williams DA, Kapur R, Atkinson SJ, Clapp DW (2003) Neurofibromin-deficiant Schwann cells secrete a potent migratory stimuli for Nf1 +/-mast cells. J Clin Invest 122:1851–1861.
Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N (2007) Bone mineral density in children with neurofibromatosis 1. Acta Paediatr 96:1220–1222.
Yu X, Milas J, Watanabe N, Rao N, Murthy S, Potter OL, Wenning MJ, Clapp WD, Hock JM (2006) Neurofibromatosis type 1 gene haploinsufficiency reduces AP-1 gene expression without abrogating the anabolic effect of parathyroid hormone. Calcif Tissue Int 78: 162–170.
Yüksel H, Odabasi AR, Kalkas S, Omur E, Turgut M (2003) Clitoromegaly in type 2 neurofibromatosis: a case report and review of the literature. Eur J Gynaecol Oncol 24: 447–451.
Yumoto E, Nakamura K, Mori T, Yanagihara N (1996) Parapharyngeal vagal neurilemmoma extending to the jugular foramen. J Laryngol Otol 10: 485–489.
Zanca A, Zanca A (1980) Antique illustrations of neurofibromatosis. Int J Dermatol 19: 55–58.
Zatkova A, Messiaen L, Vandenbroucke I, Wieser R, Fonatsch C, Krainer AR, Wimmer K (2004) Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. Hum Mut 24: 491–501.
Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296: 920–922.
Zlotogora J (1993) Mutations in von Recklinghausen neurofibromatosis: an hypothesis. Am J Med Genet. 46: 182–184.
Zvulunov A, Barak Y, Metzker A (1995) Juvenile xanthogranuloma, neurofibromatosis and juvenile chronic myelogenous leukaemia. World statistical analysis. Arch Dermatol 131: 904–908.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag/Wien
About this chapter
Cite this chapter
Ruggieri, M., Upadhyaya, M., Rocco, C.D., Gabriele, A., Pascual-Castroviejo, I. (2008). Neurofibromatosis type 1 & Related Disorders. In: Ruggieri, M., Pascual-Castroviejo, I., Di Rocco, C. (eds) Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes. Springer, Vienna. https://doi.org/10.1007/978-3-211-69500-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-211-69500-5_3
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-21396-4
Online ISBN: 978-3-211-69500-5
eBook Packages: MedicineMedicine (R0)